Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial Academic Article 2022 uri icon

authors

  • Amat-Santos IJ
  • Romaguera R
  • Sánchez-Recalde Á
  • Diez-Gil JL
  • Lopez-Otero D
  • Gheorge L
  • Ibáñez B
  • Iñiguez-Romo A
  • Raposeiras-Roubín S
  • Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) Investigators
  • RUIZ NODAR, JUAN MIGUEL
  • Sánchez-Luna JP
  • Abu-Assi E
  • Melendo-Viu M
  • Cruz-Gonzalez I
  • Nombela-Franco L
  • Muñoz-Garcí AJ
  • Blas SG
  • de la Torre Hernandez JM

publication date

  • 2022